Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

Summary

The purpose of this study is to evaluate if omalizumab co-treatment may allow reintroduction of honey bee venom immunotherapy in patients with immunotherapy treatment failure due to systemic reactions.

Timeline

Start

2014-03

Primary completion

2017-03

Completion

—

Drugs

Indications